Quanterix Corporation, a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that President and Chief Executive Officer Masoud Toloue will present at the Goldman Sachs 46th Annual Global Healthcare Conference in Miami, Florida on Monday, June 9th, at 1:20 p.m. ET.  Quanterix will also host one-on-one meetings with institutional investors during the conference.

 

Webcast Information

The live webcast presentation can be accessed from the Investors section of the company’s website at www.quanterix.com. A replay of the webcast will be available for a limited period following the conference.

 

To learn more about Quanterix, visit www.quanterix.com/company. To learn more about Quanterix’s Simoa® technology, visit www.quanterix.com/simoa-technology.

 

Source & Image Credit: Quanterix




Latest Articles

Quanterix, Masoud Toloue, biomarker detection, Simoa, healthcare conference, ultrasensitive diagnostics, institutional investors, life sciences, Goldman Sachs Quanterix CEO Masoud Toloue to present at Goldman Sachs Global Healthcare Conference on 9 June.